38 citations
,
September 2017 in “Journal of zoo and wildlife medicine” This study describes the successful management of Andean bear alopecia syndrome in three female bears using oclacitinib, leading to rapid pruritus resolution and fur regrowth without adverse effects.
19 citations
,
April 2019 in “Veterinary dermatology” This study observed that oclacitinib, combined with oral glucocorticoids, achieved rapid and lasting clinical remission in four dogs with refractory juvenile-onset ischaemic dermatopathy, suggesting oclacitinib's potential as a useful immunosuppressive treatment in such cases.
6 citations
,
January 2019 in “Journal of feline medicine and surgery open reports” This case report describes the first known occurrence of urticaria pigmentosa in a domestic shorthair cat, where oral dexamethasone and cetirizine hydrochloride offered effective management following a comprehensive diagnostic work-up.
2 citations
,
April 2021 in “Naukovì gorizonti” In this study, researchers observed that using a combination of medications, including Bravecto, Cefuroxime, Orungal, Apoquel, and Derinat, effectively treated pododermatitis in dogs, increasing therapy success from 28.6% to 66.7%, and reducing treatment duration while extending remission periods.
May 2026 in “International Journal of Advanced Biochemistry Research” In this case study, a three-year-old Labrador with canine atopic dermatitis showed significant improvement in pruritus and skin lesions after treatment with oclacitinib and supportive therapy over a one-month follow-up.